Comment: FTC weighing in on more antitrust pharmaceutical cases
The US Federal Trade Commission has been unusually active in private antitrust cases involving pharmaceuticals this year, filing five amicus briefs with US appeals courts. In its latest foray, the agency...To view the full article, register now.
Already a subscriber? Click here to view full article